Vibrio Diagnostics Market to Record Sturdy Growth by 2019

Vibrio is a genus of anaerobic, non-spore forming, gram-negative bacteria that are curved rod shape. All the species of the vibrio genus are motile pathogens and have flagella with sheaths. Several species of these bacteria are capable of causing various conditionssuch as cholera, gastroenteritis, primary septicemia, cell necrosis and otitis. Some of the diagnostic techniques used for the detection of various diseases associated with vibrio are Enzyme Immunoassays (EIA), PCR

Flow Cytometry, Monoclonal Antibodies, Diagnostic Imaging, Immuno-PCR, Fluorescent Immunoassays and Immunoprecipitation.

Some of the end-users of vibrio diagnostics techniques are Public Health Laboratories, Hospitals, Private and commercial diagnostic labs.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2271

Geographically, Asia-Pacific is expected to lead the Vibrio Diagnostics Market due to factors such as poor sanitation, unsafe drinking water and unhygienic living conditions. According to the Centers for Disease Control and Prevention (CDC) disease such as Cholera, caused by Vibrio cholera, is rare in the U.S. and other developed nations. However, the disease is predominantly present in tropical regions including Southeast Asia, Africa and Middle East countries. According to an another report by the CDC, in 2011, globally almost 58 countries registered 589,854 cases of cholera and approximately 7,816 deaths from cholera to WHO in the same year.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2271

The market for vibrio diagnostics market is primarily driven by the initiation of rapid diagnostics tests, rising awareness and increased healthcare expenditure. The market is also expected to witness growth due to other factors such as quick outcome, affordability of the diagnostics kits and devices. Furthermore, development of advance diagnostics techniques such as Polymearse Chain Reaction (PCR) and Enzyme Immunoassays (EIA) are also expected to the drive the market.

Some of the major players in this industry segment include Abbott Laboratories, Becton, Dickinson and Company, DiamedixImpex S.A., Eiken Chemical Co. Ltd., Fujirebio Diagnostics Inc., Hologic Inc., Kreatech Holding BV, Lonza Group, Novartis Diagnostics and F. Hoffmann-La Roche Ltd.

View Report -

https://www.transparencymarketresearch.com/vibrio-diagnostics-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.